Find an expert

Senior clinical pharmacist with 3 decades of experience in many facets of the pharmaceutical industry in both Australia and the UK- including work for Queensland Health as clinical pharmacist, clinical educator and team leader, National Prescribing Service academic detailer, Australian Pharmacy Council subject matter expert, Kidney Health Australia clinical advisory committee, CARI guideline working group member, Advanced Pharmacy Australia (AdPha) leadership group chair, and working as a community pharmacist and Home Medicines Review facilitator and provider.

Nick Shaw was appointed to the School as Professor in January 2004 and undertook the role of Head of School of Pharmacy at UQ from 1st July 2004 until 31st December 2014. Nick is a pharmacist, graduating PhD from the University of Manchester in 1985 and was a member of the academic staff of the University of Nottingham from 1985-2003. He was appointed a Fellow of the Royal Society of Chemistry in 1994 and a Fellow of the Royal Pharmaceutical Society in 2010. He previously founded and chaired the Council of Pharmacy Schools (Australia and New Zealand); he is the chair of the APC Accreditation Committee and was the chair of the Australian Pharmacy Liaison Forum in 2011. He has taught across a range of subjects to the second and third years of the BPharm (Hons) course at UQ. Nick has supervised and co-supervised over 45 PhD and research Masters students.

In 2013 Nick was awarded the Pharmaceutical Society of Australia’s Bowl of Hygeia for services to the profession.

Dr Shakti Shrestha is a Research Fellow/Senior Research Officer with an academic role at the School of Pharmacy and Pharmaceutical Sciences, The University of Queensland (UQ). His research role mainly involves conducting and supporting an Australian Government funded (Dementia Ageing and Aged Care Mission Medical Research Future Fund) research on improving the Quality Use of Medicine in Australian Residential Aged Care via the role of knowledge broker pharmacist (the EMBRACE project). His academic role involves course coordination and teaching UQ's Quality Use of Medicines courses for Bachelor of Pharmacy degree.

Shakti obtained his PhD at UQ School of Pharmacy, which focused on optimising medication use in older adults with limited life expectancy, drawing his extensive experience working and researching in a clinical medicine and aged care environment. He was a recipient of the 2018 Australian Research Training Scholarship at UQ for his doctoral degree. He also received the 2022 Career Development Scholarship from UQ that allowed him to develop clinical trial skills at Queensland Health, Sunshine Coast University Hospital, Townsville University Hospital and Gold Coast Private Hospital.

Shakti received his Master's degree in Clinical Pharmacology from the University of Aberdeen (UK) in 2010 and had an opportunity to work with the International Stroke Registry data called SITS-ISTR (Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Registry) in the National Health Service (NHS) Grampian Hospital, UK. He received his undergraduate Pharmacy degree from Pokhara University (Nepal) in 2007 and is registered as a Pharmacist both in Nepal and Australia.

Shakti has supervised nine pharmacy undergraduate thesis (4-years BPharm program) to completion in Nepal, and supervised several undergraduate and masters research project students. He continues to supervise a number of independent research projects mainly with the intention to support the capacity building of health professionals in research; these research often make into publications.

Shakti has research expertise in the field of geriatric and palliative medication use and safety, quality use of medicine, pharmacy practice and health services. He has research methodology expertise on systematic review, clinical research design, predictive model development, meta-analysis, medical statistics and qualitative research. He has more than 10 years of experience working in research, academic and clinical roles nationally and internationally.

Update Profile

Emeritus Professor Maree Smith AC FTSE FAHMS is a full-time researcher and Director, CIPDD, School of Biomedical Sciences, Faculty of Medicine, The University of Queensland.

In the 12 years prior to her current appointment, Professor Smith led a high-performing team in building the CIPDD and its commercial interface TetraQ, recognized as a unique, GLP-accredited drug development Centre in Australia. Professor Smith has considerable expertise in biomedical discovery/translation with specialist expertise in the novel pain therapeutics discovery/translation field encompassing a portfolio of 16 rodent pain models that mimic individual human pain conditions. This portfolio of models conducted in a purpose-built facility operated in accordance with the requirements of our Quality Management System, making the CIPDD unique in Australia and rare internationally.

In the 15 years prior to establishing the CIPDD, Professor Maree Smith was a full-time academic in the School of Pharmacy. In brief, she joined the School of Pharmacy as a Lecturer in 1989 and was successively promoted through the academic ranks to Professor in 2004. Prior to that she undertook a PhD and early postdoctoral training in clinical pharmacology with specialist expertise in bioanalytical method development, bioanalysis of human plasma samples, drug metabolism and clinical pharmacokinetics. Her second postdoc was in the field of pain management and pain pharmacology.

In the years, 1990-2005, Maree Smith taught in the Drug Discovery stream of the 2nd, 3rd & 4th years of the undergraduate Pharmacy program and she was instrumental in developing innovative courses for the final year of the undergraduate Pharmacy curriculum. She was also instrumental in the development of a course for the M Biotech program at UQ entitled “Quality Systems in Biotechnology” which continues to this day and is a compulsory course in the Program. Maree has successfully advised/co-advised to completion 33 PhD students, 2 Research Masters students and ~50 Honours students. She also served for 14 years as an external evaluator for the TGA.

Maree's Current Research Interests are as follows:

1. Subtle differences in the pathobiology of individual chronic pain conditions

2. Improving preclinical to clinical translation in novel analgesics development

3. Preclinical drug development of novel pain therapeutics

4. Preclinical drug development

Awards

2021 UQ Fellowship

2019 Companion of the Order of Australia (AC) in the Queen's Birthday Honours List

2018 Honorary Bragg Membership (The Royal Institution of Australia)

2016 Bowl of Hygeia Award (Pharmaceutical Society of Australia)

2016 Clunies Ross Knowledge Commercialisation Award (ATSE)

2015 Honoured to be included in inaugural list of Australia's top Innovators; viz Knowledge Nation 100

2015 Inaugural Inductee into the Life Sciences Queensland (LSQ) Hall of Fame

2015 Johnson and Johnson Innovaton AusBiotech Industry Excellen Award - Outstanding Leader category.

2015 Elected Fellow, Australian Academy of Health and Medical Sciences (AAHMS)

2015 Australian Pain Society Distinguished Member Award - For services to the promotion, treatment and science of pain management and lifelong contribution to the Australian Pain Society

2013 UQ Top 5 Inventor - Award by Thomson Reuters and UQ at inaugural Awards

2013 UQ Top 5 Innovator - Award by UniQuest Pty Ltd and UQ at inaugural Awards

2012 Queensland Life Sciences Industry Excellence Award jointly with Dr Jim Aylward

2011 Elected Fellow, Australian Academy of Technological Sciences (ATSE)

2009 Honorary Fellowship, Faculty of Pain Medicine, ANZCA (Australian and New Zealand College of Anaesthetists).

2008 WiT (Women in Technology): Biotech Outstanding Achievement Award

2002 Meritorious Mention for Sustained Excellence in Research Higher Degree Supervision

2001 Meritorious Mention for Sustained Excellence in Research Higher Degree Supervision

I am a senior researcher with cross-disciplinary expertise in health economics, pharmacy practice, and virtual health solutions. I am passionate about optimising healthcare outcomes by developing economically sustainable services that use technology and artificial intelligence to empower patients. My work explores the economic efficiency of implementing either virtual health or advanced-scope clinician initiatives within the Australian health system to improve patient care.

I am also a clinical pharmacist with more than a decade of experience in patient care and clinician training. I am a health economist at the UQ Centre for Online Health, and I lead the research work in the Pharmacy Department at the Princess Alexandra Hospital in Brisbane.

Christine graduated with a Bachelor of Pharmacy degree (honours class 1) from the University of Queensland in 1996.

She registered as a pharmacist in Australia in 1997 and in the United Kingdom in 2003 and has worked at the Redlands, Princess Alexandra and Wesley Hospitals in Brisbane and the Western Infirmary in Glasgow. In 2002 she was awarded a PhD from the University of Queensland, with a thesis focusing on improving usage of the immunosuppressant agent tacrolimus in solid organ transplant recipients.

In 2004 she was the recipient of a National Health and Medical Research Council (NHMRC) Neil Hamilton Fairley fellowship. This award enabled her to training overseas in the field of Pharmacometrics within the Department of Medicine and Therapeutics at the University of Glasgow (Scotland) and the Department of Pharmaceutical Biosciences at Uppsala University (Sweden).

On her return to Brisbane, Christine was the recipient of a Lions Medical Research Fellowship and was the chief investigator on a three year NHMRC Project Grant. She has also been a team member on an Amgen-Transplant Society of Australia and New Zealand Research Grant and a Cellcept Australia Research Grant. Over her research career Christine has attracted grants and awards totaling more than 2 million AUD from various funding agencies.

Research Interests

Christine has a wide range of interests in the fields of Quality Use of Medicine and Pharmacometrics. Her work to date has primarily been directed towards optimising usage of immunosuppressant drugs in solid organ transplant recipients and antibiotics in patients with life-threatening infections.

Christine has published over 75 peer reviewed papers and 90 conference abstracts on these topics. Her publications have been cited on more than 3200 occasions, with twelve cited more than 50 times.

Christine has successfully supervised to completion fourteen higher research degree students and enjoys helping students meet their career goals.

Christine’s current projects include:

• Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
• Comparing the efficacy and safety of continuous versus intermittent administration of beta-lactams in critically ill patients
• Examining the relationship between immunosuppression and non-melanoma skin cancer in renal transplant recipients
• Improving individualisation of immunosuppressant therapy in adult kidney transplant recipients
• Improving gentamycin dosing in paediatric oncology patients
• Examining tobramycin monitoring in cystic fibrosis patients in Australia and the United Kingdom
• Investigating the relationship between prednisolone exposure and drug-related toxicity in paediatric and adult kidney transplant recipients
• Comparing different therapeutic drug monitoring methods for dosage adjustment of once daily intravenous tobramycin treatment in children with cystic fibrosis

Projects currently available for interested research higher degree students include:

• Dose optimisation of busulfan in paediatric bone marrow transplant recipients
• Investigating the relationship between immunosupressant exposure and drug-related toxicity in transplant recipients
• Examining Bayesian forecasting methods to predict immunosuppressant exposure
• Examining the international use of immunosuppressant and anti-rheumatic drugs
• Examining the influence of plasma exchange on immunosuppressant drug exposure

Christine invites potential honours and post-graduate students to contact her via email to discuss research opportunities.

Teaching interests

Co-ordinates:

• PHRM3052- Biological Fate of Drugs

Teaches in:

• PHRM3052- Biological Fate of Drugs
• PHRM3011- Quality Use of Medicines

I completed my Bachelor of Pharmacy at Kings College London, followed by pre-registration and subsequent employment as a pharmacist with Boots the Chemists in Central London. With a PhD in plant biochemistry with Royal Holloway College, University of London, and the Royal Botanic Gardens, Kew, I moved first to Cornell University, USA and then The University of Western Australia for postdoctoral research. I moved to the School of Pharmacy at The University of Queensland in 2007.

Following a number of years in plant research, my current research interests generally link back to plants in some way. Many of my projects develop in response to requests for help from healthcare professionals, and so I have a strong focus on answering clinical questions using pharmaceutical science methods. See my research interests for more information.

I teach into the Bachelor of Pharmacy (Honours) in the areas of pharmaceutics, compounding and complementary medicines. I also teach the clinical drug development course for our Master of Pharmaceutical Industry Practice. I am currently the Director of Teaching, Learning and Student Experience for the School of Pharmacy. I have supervised 28 PhD students to completion, and over 60 undergraduate and masters independent research project students.

I am a medicinal and organic chemist

Studied organic chemistry at the University of Sydney, moved to UQ in 1993, then worked for Bayer in Germany, before moving back to Australia in 1996. Worked in Melbourne at the Victorian College of Pharmacy (now MIPS). I then returned to UQ in 2000 to the Fairlie lab where we design and synthesise new chemical entities to tackle human disease. Since 2012 I have been on extended medical leave and am currently an Adjunct Research Fellow, researching proteins from flaviviruses such as Dengue, West Nile, and Zika viruses, and the coronaviruses SARS, MERS, and SARS-CoV-2.

Critical Care Medicine focuses on supporting patients, often with one or multiple organ failures. Based at the largest Australian cardiac hospital, our research investigates better ways to support patients with heart and/or lung failure. We explore technological, pharmacological and engineering advances that could help our patients to live longer and better. Our group is world-renowned for clinically relevant large animal models, including heart failure, respiratory failure (ARDS), heart transplantation, sepsis, cardiogenic shock, and more. All our studies use hospital-grade equipment and follow the same clinical guideline to maximise translation. We actively take on honours, MPhil and PhD students from multi-disciplinary backgrounds (science, engineering, medicine, allied health), with a successful track record in supporting our students to secure their own grants and funding. Students are expected to contribute to other studies of the group. For more information about the group, please visit ccrg.org.au, and email if you are interested to join us.

Tim is a clinical pharmacist and conjoint lecturer working at the School of Pharmacy and the Princess Alexandra Hospital. He graduated from the Bachelor of Pharmacy at the University of Queensland in 2014. After working in mental health at the Princess Alexandra Hospital, he become interested in schizophrenia and psychopharmacology. He began his PhD with the School of Clinical Medicine in 2020 and his research interests include clozapine, treatment refractory schizophrenia, and the safe use of antipsychotic medicines. He is the team leader of mental health pharmacy at the Princess Alexandra Hospital. Tim teaches into the Bachelor of Pharmacy and the Masters of Clinical Pharmacy programs at the University of Queensland, and supervises research project placements.

Wubshet is an accredited pharmacist, lecturer, and Mental Health First Aid Instructor at the University of Queensland’s Faculty of Health and Behavioural Sciences. He also holds an Affiliate Research Fellow position at the University of Sydney School of Pharmacy. Currently, he is a course coordinator for Pharmacy Practice and Medicines Management in the BPharm (Hons) program.

He completed his PhD at the University of Tasmania in 2019. Following that, he held postdoctoral researcher roles at the University of Canberra and University of Sydney, where he coordinated multiple government- and industry-funded clinical trials.

Wubshet's research primarily centres around understanding medication and patient outcomes in individuals with chronic diseases, with a special emphasis on kidney diseases. In collaboration with several researchers and stakeholders in Australia, Wubshet has attracted ~$2.1 million in grant funding. Currently, he is actively involved as an investigator in a large-scale cluster randomised trial (ACTRN12622000329763) funded by the Medical Research Future Fund and led by the University of Sydney. This trial is investigating the effectiveness of a community pharmacy-led point-of-care screening in improving the detection of chronic kidney disease and quality use of medicines.

Professor Susan Tett is a registered pharmacist with research interests in Quality Use of Medicines (improving how medicines are used) and clinical pharmacokinetics (optimising medicine doses)

Sue completed her PhD in 1988. Since this time she has been in research positions and in academia at Sydney University, St Vincent’s Hospital, Sydney and at the University of Queensland. She has over 150 peer reviewed research publications and over 200 conference presentations and is on Editorial Board of Clinical Pharmacokinetics. Sue was Head of the School of Pharmacy, University of Queensland 1996-2004 and Deputy Executive Dean & Associate Dean Research for the Faculty of Health Sciences 2006-2010, including periods as Acting Executive Dean.

Susan Tett has been a member of many Australian national and State advisory committees, including Pharmaceutical Health and Rational use of Medicines Committee 1996-2004, Pharmaceutical Sub-Committee of the Australian Drug Evaluation Committee 1995-2004, Pharmaceutical Industry Working Group 2003-10 , Pharmaceutical Partnerships Program Committee of the Industry Research & Development Board 2003-09, and has participated in NHMRC Project Grant Review Panels and Fellowships Panels. She was also Councillor for the Pharmaceutical Society of Australia (Queensland Branch) and was the Australian Pharmacist of the Year in 1999, for her contributions to pharmacy education and research.

Sue’s research interests are directed towards optimising the clinical use of medications. General areas of research include quality use of medicines, clinical pharmacokinetics and pharmacodynamics. Sue supervises a number of postgraduate students and is actively involved in innovation in the pharmacy profession, pushing the professional boundaries. She is committed to enhancing the role of the health care team in optimising consumer health outcomes.

I am an NHMRC Leadership Fellow with joint apointments at the Institute for Molecular Bioscience (IMB) and School of Pharmacy, UQ. My research interests lie in the fields of peripheral pain mechanisms, target identification and analgesic drug discovery. I investigate the contribution of ion channels to sensory neuronal physiology using highly subtype-selective toxins isolated from venomous animals with the aim to develop novel analgesics with improved efficacy and tolerability.

Dr Walweel is an electrophysiologist specializing in calcium-released channels (RyR2) regulation in heart. Walweel's research project is to understand how RyR2 regulates heart contraction and rhythm, how their dysregulation leads to cardiac arrhythmias, and how pharmacological interventions targeting RyR2 restore normal heart rhythm. She is expert in bilayer work, single channel recording and biochemistry. Walweel's discoveries are clinically important for understanding arrhythmia generation in patients with heart failure and CPVT. Dr Walweel works with the purpose to promote human heart research and health. She aims to reduce heart failure burden and death by advancing pathophysiological research and discovering suitable medication to prevent arrhythmias. Over a relatively short time, Dr Walweel's research resulted in notable and meritorious publications in high quality journals (JACC, Circ Res, Mol Pharmacol, J Gen Physiol, J Mol Cell Cardiol and J Biomed Sciences).

Dr Haolu Wang currently is a Medical Registrar and Basic Physician Trainee with the Royal Australasian College of Physicians - The Prince Charles Hospital and Redcliffe Hospital (Northside) Rotation. He is also an Honorary Research Fellow in the joint liver cancer research program of Frazer Institute, The University of Queensland and Gallipoli Medical Research Foundation. Dr Wang received his Bachelor of Medicine and Master of Surgery qualifications from Shanghai Jiao Tong University School of Medicine. He was awarded his PhD in Clinical Medicine from The University of Queensland. Dr Wang has worked as a Medical Officer at Renji Hospital, Shanghai Jiao Tong University School of Medicine and as a Researcher Officer at Frazer Institute, The University of Queensland.

Dr Wang has authored over 30 publications of clinical and translational research in liver diseases, including Hepatology, Theranostics, Int J Cancer, J Exp Clin Cancer Res and Pharmacol Ther. His standing in this field is reflected by awards from Australian National Health and Medical Research Council, United European Gastroenterology, European Microscopy Congress, The University of Queensland, Frazer Family Foundation and Shanghai Jiao Tong University.

Associate Professor

Pharmacy Australia Centre of Excellence Email: karen.whitfield@uq.edu.au

Dr Karen Whitfield is an Associate Professor within the School of Pharmacy and is the Program Lead for the Master of Clinical Pharmacy.https://future-students.uq.edu.au/study/programs/master-clinical-pharmacy-5718

Karen was awarded the Research Excellence Award for Research Support - Metro North Health Service in 2020 and the Australian Clinical Pharmacist awarded by the Society of Hospital Pharmacists of Australia in 2017

Karen has worked at a number of different hospital including Royal Brisbane and Women's Hospital, Leicester Royal Infirmary, Leicester General Infirmary, North Staffordshire Hospital Trust (Surgical and Paediatric Directorate Pharmacist), The Townsville Hospital. Most recently she has worked at the Royal Brisbane and Women’s Hospital (from 2015-2021) holding several positions including, Team Leader Women's and Newborns and Assistant Director Cancer Care Services. She has also held a number of teaching positions including, Sr Lecturer James Cooke University, Teacher Practitioner with Medicines Services Queensland and lecturer with the University of Queensland.

Her specialist interests include Women's Health and Neonatology

She completed a Diploma in Hospital Pharmacy (1991), Masters in Clinical Pharmacy (1996) and completed her PhD at Aston University in 2002 under the supervision of Dr John Marriott and Dr Keith Wilson at the Birmingham Children’s Hospital UK, investigating sedatives in the Paediatric Intensive Care Unit.

Karen has presented work Nationally and Internationally at several Seminars and Conferences including, Life Long Learning for Pharmacists Conference (Dublin 2020, Croatia 2016), FIP webinar series ‘Hearing from our Hero’s’ (2020), Monash Pharmacy Education Symposium (2019), MM2018 SHPA Conference Brisbane (2018), Neonatal and Paediatric Pharmacists Conference UK (2015), Society of Obstetric Medicine Australia and New Zealand (Melbourne 2015).

Dr Woodruff is a Professor of Pharmacology who leads a research team aiming to find new therapeutic treatments for neurodegenerative disorders. Current therapies for these diseases are vastly inadequate, and so new research is needed to identify novel targets to slow or halt their progression. Prof Woodruff’s specific research revolves around the innate immune system in the brain, and the role of neuroinflammation in propagating disease. A key focus of his current work is testing new drugs developed at the University of Queensland in models of motor neuron disease (amyotrophic lateral sclerosis), Huntington’s disease, and Parkinson's disease, as well as maintaining an active interest in acute inflammatory disorders including sepsis and ischemia-reperfusion injuries. Using a series of potent and orally active complement C5a and NLRP3 inflammasome inhibitors developed at UQ, Prof Woodruff's team has demonstrated the therapeutic potential of targeting innate immune-mediated neuroinflammation to reduce neuronal cell death in animal models of these neurodegenerative diseases. His team has recently shown that in addition to their roles in neurodegeneration, innate immune factors also play essential roles in stem and neuronal cell development during embryogenesis, revealing the widespread physiological and pathological roles of this evolutionarily ancient immune system.

Dr Zyta Ziora received PhD (Wroclaw University of Science & Technology, Poland) in chemistry and has wide range of experience in development of antimalarial therapeutics (the University of Montpellier, France), antibacterial agents, enzyme inhibitors and drug candidates against Alzheimer disease (Kyoto Pharmaceutical University, Japan). Her research time is currently dedicated mainly to projects devoted to the modification of existing antibiotics, and complexing them with additional antimicrobial agents, like metal ions, to produce more potent alternatives and by this to overcome the drug resistance of superbugs. She is also working on alternative to antibiotics nature-derived compounds with antimicrobial and anticancer potency, such poliphenolic derivatives to control tyrosinase function.